Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Refobacin Bone Cement R (110034355)

K-Number: K254107 · 2026-04-15

ApplicantBiomet France
Decision Date2026-04-15
Product CodeLOD
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Refobacin Bone Cement R (110034355) is the device name listed in this FDA 510(k) record. The listed applicant is Biomet France. It received FDA 510(k) clearance on 2026-04-15 under 510(k) number K254107. The device is classified under product code LOD. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Refobacin Bone Cement R (110034355)?

Refobacin Bone Cement R (110034355) is a medical device that received FDA 510(k) clearance on 2026-04-15. The listed applicant is Biomet France. The 510(k) number is K254107.

When did Refobacin Bone Cement R (110034355) receive FDA 510(k) clearance?

Refobacin Bone Cement R (110034355) received FDA 510(k) clearance on 2026-04-15, under 510(k) number K254107.

Who is the listed applicant for Refobacin Bone Cement R (110034355)?

The FDA 510(k) record lists Biomet France as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Refobacin Bone Cement R (110034355)?

The FDA product code for Refobacin Bone Cement R (110034355) is LOD.

Related Devices (Code: LOD)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.